| Literature DB >> 17320506 |
Peter A Jones1, Stephen B Baylin.
Abstract
Aberrant gene function and altered patterns of gene expression are key features of cancer. Growing evidence shows that acquired epigenetic abnormalities participate with genetic alterations to cause this dysregulation. Here, we review recent advances in understanding how epigenetic alterations participate in the earliest stages of neoplasia, including stem/precursor cell contributions, and discuss the growing implications of these advances for strategies to control cancer.Entities:
Mesh：
Year: 2007 PMID： 17320506 PMCID： PMC3894624 DOI： 10.1016/j.cell.2007.01.029
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582